Local PPC activity, such as from PACE4, may regulate BMP‐10 bioavailability in endothelial subsets, potentially contributing to HHT and enhancing the susceptibility to AVMs.60, 61. The gene discussed is BMP10; the disease is hereditary hemorrhagic telangiectasia.